In lung adenocarcinoma, COPB2 was confirmed to be overexpressed and negatively correlated with survival, and COPB2 downregulation enhanced apoptosis and repressed proliferation and tumorigenesis in lung adenocarcinoma cells [31]. This evidence concerns the gene COPB2 and lung adenocarcinoma.